$Recursion Pharmaceuticals, Inc.(RXRX)$ 🐂

Yo, Tiger squad! 🐯💖 I’m your girl, totally obsessed with Recursion Pharmaceuticals ($RXRX) and even though their Q4 earnings took a major spill, I’m stan-ing this AI biotech queen SO hard, she’s still my ultimate vibe. 🚀 This dip? It’s basically a golden glow-up opportunity, and I’m looking at jumping in Monday at open, here’s why I’m feeling it, besties, and trust, it’s about to pop off!

🔴 Okay, Q4 was a total mess: EPS hit -$0.53 📉, revenue’s at $4.55M (up 58% YoY, but missed that $18.2M whisper by 75%), and they’re deep in the red with R&D at $98.3M (42% YoY) and G&A at $77.2M (153% YoY). But spill the tea, these expenses? They’re pouring EVERY dime into their iconic AI platform, making massive R&D moves. Roche & Genentech collab delays hit, but that’s just a vibe check, not a dealbreaker. A month ago, they were slaying with a 21% yearly gain, confidence is still there, fam!

📉 The stock took a hit, but context is everything. It’s up 21% over the year and +37% YTD, $RXRX is still one of 2025’s top growth plays. This dip? Looks like a VIP pass for us trendsetters who missed the rally. I’m not sweating it, they’ve got the juice to bounce back!

🤖 AI Drug Discovery = Straight Fire 🔥

They just dropped REC-7735, a preclinical baddie matching Scorpion’s STX-478 (the one Lilly snatched for $2.5B). When big pharma’s throwing BILLIONS at AI-driven drug discovery, you know Recursion’s the ultimate vibe. AI + drugs = the most iconic cheat code ever. 💻💊 I’m living for this innovation, no cap!

💎 Cathie’s #1 Pick in ARKG

Aunt Cathie Wood is riding this rocket like it’s her personal playlist, $RXRX is the top holding (8.9%) in ARKG, outranking Tempus AI & Twist Bioscience. And get this: ARK’s buying MORE shares on the dip. She’s basically handing us a cheat sheet, fam and I’m taking notes! 👀💰

📈 Tech’s Whispering Bullish AF

MACD? Trending up like my fave TikTok sound. RSI? Not even overbought, perfectly chill. VMA spikes on dips = buyers lurking hard. This chart’s setting up for a potential bounce, and shorts might just get wrecked if momentum hits. Manifesting a major glow-up, 100%, it’s giving “chart baddie” energy!

🔥 Big Money, Smart Tech = LFG Vibes

Recursion’s leading the AI-powered biotech frontier—data + drugs = massive 💰 potential. Meanwhile, some old-school pharma’s still stuck in 1999 with their dusty Excel spreadsheets. 🙄 Not here for that—$RXRX is where the future’s popping off, and I’m all in on the flex!

🎯 Final Tea: This dip is basically a VIP pass into a game-changing AI biotech play. I’m locking in positions Monday—I’m 1000% confident they’ll bounce back HARDER than ever. Where’s your buy zone, Tiger queens? 😏 Slide into my DMs or drop it below—I need to know your moves, besties!

📢 Tiger Traders: Snatching $RXRX at open, or waiting for a deeper discount? Let’s spill ALL the tea and flex our strategies! 🥰

: Is this chart setting up for a *major* glow-up, or still throwing caution flags? Break it down, fam, I need ALL the deets to stay savage!

Stay savage, stay shiny, your girl’s all in, ready to flex, and glowing up with $RXRX! 🔥

Kiwi Tigress 🐅 🔥💚

@Tiger_comments @TigerStars @TigerPicks @TigerWire